Financial statements Europharma Alliance

Cash flow statement of Europharma Alliance

Company age:
Age:
18 y. 4 m. 13 d.
Share capital:
Share capital:
200 000 PLN
Profit and loss statement Balance Cash flow Profitability

Cash inflows of EUROPHARMA ALLIANCE

Year
2018
2019
2020
2021
2022
2023
Net cash from operating expenses - - 3 167 956,86 9 890 682,59 207 094,87 5 780 745,64
Net cash flow from investing activities - - -746 641,11 -5 539 053,96 -5 026 810,20 1 187 685,22
Net cash flow from financial activities - - -2 308 199,52 -223 978,63 -683 110,59 -919 535,36
Total net cash flow - - 113 116,23 4 127 650,00 -5 502 825,92 6 048 895,50
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.